Pygeum vs Saw Palmetto and Nettle

Table of Contents

1. Three Plants, One Shelf
2. Saw Palmetto: the Largest Evidence Base
3. Pygeum: Positive but Older
4. Nettle Root: Mostly in Combinations
5. No Head-to-Head Trials
6. When Reviews Rank the Same Herbs Differently
7. Compared With Standard BPH Drugs
8. Proposed Mechanisms Compared
9. Combination Products and the Hair-Loss Crossover
10. The Three Herbs Side by Side
11. Key Research Papers
12. Connections

Three Plants, One Shelf

• Saw palmetto — a fat-soluble ("lipido-sterolic") extract of the berries of a dwarf palm from the south-eastern United States. Described in a 2000 review as "the most widely used phytotherapeutic agent for BPH".
• Pygeum — an extract of the bark of a large African forest tree; wild-harvested for most of its history and regulated under CITES since 1995.
• Nettle root — an extract of the root of the common stinging nettle, a weed of temperate regions. The leaf is used differently, for other purposes.

A 2021 review of natural BPH treatments discussed all three alongside pumpkin seed, willow herb, tomato (lycopene), maritime pine bark and rye pollen, summarising both preclinical and clinical results and safety. A 2002 review of urinary-tract botanicals likewise grouped saw palmetto fruit, nettle root and pygeum bark as the main herbs for BPH symptoms.

Back to Table of Contents

Saw Palmetto: the Largest Evidence Base

Saw palmetto has been tested more than either of the other two. The pack evidence:

• A 2000 systematic review by the Cochrane group's Minneapolis team analysed 18 trials involving 2,939 men. Compared with placebo, saw palmetto reduced nocturia (weighted mean difference −0.76 times per night), increased peak urine flow by 1.93 mL/s, and men were more likely to rate their symptoms as improved (risk ratio 1.72). Improvement was comparable to men taking finasteride. The reviewers concluded that saw palmetto, alone or combined, had "the strongest evidence for efficacy and tolerability" among the phytotherapies.
• A 2019 Italian review summarised recent meta-analyses as finding saw palmetto's effectiveness "similar or inferior" to finasteride and tamsulosin, but clearly higher than placebo, for mild and moderate symptoms.
• Reviews in 2015 and 2016 concluded that more recent, larger and more soundly constructed studies found no significant benefit of phytotherapy over placebo.
• A 2023 US family-medicine evidence review stated flatly that "saw palmetto is not effective".

In other words, published assessments of saw palmetto moved from positive in 2000 to negative by 2023. The site's Saw Palmetto: Prostate Health and BPH page covers that history in detail.

Back to Table of Contents

Pygeum: Positive but Older

• The 2002 Cochrane review analysed 18 trials involving 1,562 men: men on pygeum were more than twice as likely to report overall symptom improvement (risk ratio 2.1), with nocturia down 19%, residual urine down 24% and peak flow up 23%.
• Trials averaged 64 days; only 1 of 18 reported allocation concealment; doses and preparations varied.
• The 2000 phytotherapy review, which put saw palmetto first, said pygeum "may be a useful treatment option" but that inadequate reporting limited any firm conclusion.
• The 2023 US review that rejected saw palmetto stated that pygeum "may be effective".

So assessments of pygeum have not turned the way saw palmetto's did — but no new large pygeum trial appears in the evidence gathered for this page, so its record still rests on the older, smaller trials. Full detail: Pygeum: BPH Evidence.

Back to Table of Contents

Nettle Root: Mostly in Combinations

• The 2000 phytotherapy review found that studies of nettle (Urtica dioica) and of pumpkin seed (Cucurbita pepo) were limited, "although these agents may be effective combined with other plant extracts such as Serenoa and Pygeum".
• The same review concluded there was "no convincing evidence supporting the use of Urtica dioica or Curcubita pepo alone" for BPH.
• The 2019 Italian review placed nettle with pygeum and pumpkin seed as possible add-ons to standard therapy, supported by studies showing improved symptoms and flow.
• A 2002 review listed nettle both as a diuretic herb (the leaf and aerial parts) and, separately, as a BPH herb (the root).

The site's Nettle Root for Prostate and BPH page covers the root trials in more depth.

Back to Table of Contents

No Head-to-Head Trials

No trial in the pack compared pygeum directly with saw palmetto or with nettle root. Every comparison on this page is therefore indirect: separate trials, in different men, at different times, measured with different scales, set side by side by reviewers. Indirect comparisons of this kind are weak evidence, because differences in trial design can easily be larger than differences between the herbs.

A 2002 review went further and argued that even comparisons within one herb are risky: "as long as the composition of the final product of the various preparations is not proven to be identical, each manufacturer's preparation must be evaluated separately". A 2000 review made the same point for pygeum and saw palmetto specifically, writing that the clinical and biological activities of one preparation "cannot be extrapolated to other preparations of the same plant source".

Back to Table of Contents

When Reviews Rank the Same Herbs Differently

Two reviews twenty-three years apart illustrate how much depends on which trials a reviewer weighs:

• The 2000 systematic review ranked saw palmetto first ("the strongest evidence"), with South African star grass and rye pollen next, pygeum as possibly useful but under-reported, and nettle and pumpkin seed unsupported on their own.
• The 2023 family-medicine review reversed the top of that order: saw palmetto "not effective", pygeum and beta-sitosterol "may be effective".

The abstracts do not spell out the reasoning in full; the 2015 and 2016 reviews attribute the shift in the phytotherapy evidence generally to newer, larger and better-designed studies. Other reviews sit between these positions: a 2013 Spanish systematic review found the evidence for phytotherapy as a whole inconsistent and not supportive for BPH, while a 2020 Spanish review called pygeum an option on the strength of expert opinion.

Back to Table of Contents

Compared With Standard BPH Drugs

• Pygeum: the Cochrane review found no trial comparing it with alpha-blockers or 5-alpha-reductase inhibitors.
• Saw palmetto: the 2000 review found improvement comparable to finasteride; the 2019 review described effectiveness similar or inferior to finasteride and tamsulosin.
• Plant extracts in general: a 2013 French review of urinary drugs concluded that alpha-blockers and 5-alpha-reductase inhibitors have clearer efficacy than plant extracts for BPH symptoms.
• Standard first-line care: the 2023 review described alpha-blockers or phosphodiesterase-5 inhibitors as primary medical treatment, with 5-alpha-reductase inhibitors added for larger prostates.

Older reviews also documented how differently these products were regulated: a 2000 review noted that plant extracts were prescribed and reimbursed in parts of Europe but classified as dietary supplements in the United States, and a 2015 review reported that complementary and alternative medicines made up more than half of all filled BPH prescriptions in Europe.

Back to Table of Contents

Proposed Mechanisms Compared

All three herbs are said to act on hormones and inflammation, but the laboratory evidence is specific to each:

• Pygeum: atraric acid blocked the androgen receptor in a cell assay; extract reduced 5-lipoxygenase inflammatory products in human white blood cells in a dish; extract slowed prostate cancer cell growth and lowered cancer incidence in a mouse model. See Bark Chemistry and Mechanisms.
• Saw palmetto and plant sterols generally: a 2021 review explained that some plants are proposed to act on 5-alpha-reductase, the enzyme that converts testosterone to the more potent DHT; a 2000 industry-authored review described 5-alpha-reductase and inflammation as the targets of standardised pygeum and saw palmetto extracts.
• Beta-sitosterol, a sterol present in all three plant groups and concentrated in some pygeum products, was described in a 2019 review as improving urinary symptoms and flow but not reducing prostate size.

None of these mechanisms has been shown to explain a clinical effect in men.

Back to Table of Contents

Combination Products and the Hair-Loss Crossover

Because the three herbs are so often combined, several trials test mixtures. These can show whether a mixture works, but not which ingredient is responsible.

• Hair loss: a 2025 randomised, placebo-controlled trial of 80 men and women with chronic telogen effluvium or androgenetic alopecia tested a daily capsule of l-cystine, saw palmetto, pumpkin seed, pygeum, vitamins and minerals for six months. Hair density rose by 9.9 hairs/cm² at 3 months and 12.3 hairs/cm² at 6 months, significantly more than placebo, with no moderate or severe adverse events. Several authors were employees of the sponsoring company.
• A 2023 review of natural compounds for hair loss listed nettle, hops, saw palmetto, grape, pygeum and pumpkin seed among plants that "may be effective" in reducing hair loss, mainly on the basis of anti-inflammatory and antioxidant properties.
• For BPH, the 2000 review noted that nettle and pumpkin seed "may be effective combined with other plant extracts such as Serenoa and Pygeum".

For saw palmetto's own hair-loss research, see Saw Palmetto for Hair Loss.

Back to Table of Contents

The Three Herbs Side by Side

• Size of evidence: saw palmetto largest (18 trials, 2,939 men in the 2000 review alone); pygeum next (18 trials, 1,562 men, mostly short); nettle root smallest, mostly in combinations.
• Direction of the latest reviews: saw palmetto mixed to negative; pygeum mixed to cautiously positive; nettle alone unsupported, combinations possible.
• Head-to-head data: none between the herbs; none between pygeum and standard drugs.
• Side effects in trials: generally mild and infrequent for all phytotherapies, according to the 2000 and 2015–2016 reviews.
• Supply: pygeum bark comes from a CITES Appendix II tree (listed since 1995); the evidence gathered here describes no comparable trade restriction for saw palmetto or nettle.

Choosing among these, or between any of them and a prescription drug, is a decision the research cannot make for an individual; it belongs with a clinician who knows the person's symptoms and other medicines.

Back to Table of Contents

Key Research Papers

1. Wilt TJ, Ishani A, Rutks I, et al. Phytotherapy for benign prostatic hyperplasia. Public health nutrition. 2000;3(4A):459-72. PubMed PMID: 11276294
2. Wilt T, Ishani A, Mac Donald R, et al. Pygeum africanum for benign prostatic hyperplasia. The Cochrane database of systematic reviews. 2002;1998(1):CD001044. PubMed PMID: 11869585
3. Arnold MJ, Gaillardetz A, Ohiokpehai J. Benign Prostatic Hyperplasia: Rapid Evidence Review. American family physician. 2023;107(6):613-622. PubMed PMID: 37327163
4. Cicero AFG, Allkanjari O, Busetto GM, et al. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. 2019;91(3). PubMed PMID: 31577095
5. Csikós E, Horváth A, Ács K, et al. Treatment of Benign Prostatic Hyperplasia by Natural Drugs. Molecules (Basel, Switzerland). 2021;26(23). PubMed PMID: 34885733
6. Keehn A, Taylor J, Lowe FC. Phytotherapy for Benign Prostatic Hyperplasia. Current urology reports. 2016;17(7):53. PubMed PMID: 27180172
7. Keehn A, Lowe FC. Complementary and alternative medications for benign prostatic hyperplasia. The Canadian journal of urology. 2015;22 Suppl 1:18-23. PubMed PMID: 26497340
8. Dreikorn K. The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia. World journal of urology. 2002;19(6):426-35. PubMed PMID: 12022711
9. Levin RM, Das AK. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens. Urological research. 2000;28(3):201-9. PubMed PMID: 10929430
10. Dreikorn K. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia. Current urology reports. 2000;1(2):103-9. PubMed PMID: 12084323
11. Morán E, Budía A, Broseta E, et al. [Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma]. Actas urologicas espanolas. 2013;37(2):114-9. PubMed PMID: 23058996
12. Salinas-Casado J, Esteban-Fuertes M, Carballido-Rodríguez J, et al. Review of the experience and evidence of Pygeum africanum in urological practice. Actas urologicas espanolas. 2020;44(1):9-13. PubMed PMID: 31627963
13. Game X, Cornu JN, Robert G, et al. [Drug therapy of urethral diseases]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2013;23(15):1287-98. PubMed PMID: 24183087
14. Yarnell E. Botanical medicines for the urinary tract. World journal of urology. 2002;20(5):285-93. PubMed PMID: 12522584
15. Cristoni A, Di Pierro F, Bombardelli E. Botanical derivatives for the prostate. Fitoterapia. 2000;71 Suppl 1:S21-8. PubMed PMID: 10930709
16. Piquero-Casals J, Saceda-Corralo D, Aladren S, et al. Oral Supplementation with l-Cystine, Serenoa repens, Cucurbita pepo, and Pygeum africanum in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study. Skin appendage disorders. 2025;11(1):27-35. PubMed PMID: 39911983
17. Gasmi A, Mujawdiya PK, Beley N, et al. Natural Compounds Used for Treating Hair Loss. Current pharmaceutical design. 2023;29(16):1231-1244. PubMed PMID: 37151166

PubMed Topic Searches

1. PubMed: Serenoa repens versus Pygeum africanum
2. PubMed: Urtica dioica root and benign prostatic hyperplasia
3. PubMed: Combination phytotherapy for lower urinary tract symptoms

Back to Table of Contents

Connections

• All Herbs
• Pygeum (Prunus africana) — the main topic page
• Pygeum Benefits Hub — all four deep dives
• Pygeum: BPH Evidence — the trials in detail
• Pygeum: Bark Chemistry — the lab work
• Pygeum: Overharvesting and CITES — the supply problem
• Saw Palmetto — the main topic page
• Saw Palmetto: Prostate Health and BPH — its trial history
• Saw Palmetto for Hair Loss — the hair-loss crossover
• Stinging Nettle — the main topic page
• Nettle Root for Prostate and BPH — the root evidence
• Pumpkin Seeds: Prostate and Urinary Health — the fourth common ingredient
• Benign Prostatic Hyperplasia — the condition
• Alopecia — hair loss and its causes

Back to Table of Contents